Research Article

Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study

Table 2

The associations of the liver enzymes with demographic and selected medical and laboratory characteristics in the study participants.

CharacteristicElevated ALT valueElevated AST valueElevated GGT valueElevated ALP value

Age cat-no. (%)<0.0010.905<0.001<0.001
 35–45438 (49.27)112 (37.58)310 (30.45)215 (22.10)
 46–55268 (30.15)94 (31.54)335 (32.91)344 (35.35)
 ≥56183 (20.58)92 (30.87)373 (36.64)414 (42.55)
Gender-no. (%)<0.0010.6210.0010.827
 Female348 (39.15)155 (52.01)595 (58.45)523 (9.85)
 Male541 (60.85)143 (47.99)423 (41.55)450 (46.25)
Education-no. (%)<0.0010.090<0.001<0.001
 ≤5 years255 (28.72)122 (40.94)422 (41.49)463 (47.63)
 6–12 years444 (50.00)129 (43.29)443 (43.56)403 (41.46)
 ≥13 years189 (21.28)47 (15.77)152 (14.95)106 (10.91)
Physical activity-no. (%)0.0090.042<0.0010.006
 Low381 (42.86)135 (45.30)450 (44.20)423 (43.47)
 Moderate409 (46.01)140 (46.98)493 (48.43)460 (47.28)
 Heavy99 (11.14)23 (7.72)75 (7.37)90 (9.25)
BMI-no. (%)<0.001<0.001<0.0010.038
 <25120 (13.53)53 (17.79)167 (16.42)249 (25.62)
 25–29.9429 (48.37)123 (41.28)464 (45.62)403 (41.46)
 ≥30338 (38.11)122 (40.94)386 (37.95)320 (32.92)
WSI-no. (%)<0.0010.137<0.001<0.001
 Low213 (23.99)79 (26.51)274 (26.94)306 (31.48)
 Low-middle247 (27.82)90 (30.20)316 (31.07)276 (28.40)
 Middle-high328 (36.94)101 (33.89)372 (36.58)352 (36.21)
 High100 (11.26)28 (9.40)55 (5.41)38 (3.91)
Alcohol consumption-no. (%)<0.0010.0060.9450.045
 Yes142 (16.15)43 (14.78)101 (10.05)114 (11.83)
 No737 (83.85)248 (85.22)904 (89.95)850 (88.17)
Cigarette smoking-no. (%)0.3110.4410.049<0.001
 Yes213 (24.23)69 (23.71)232 (23.08)318 (32.99)
 No666 (75.77)222 (76.29)773 (76.92)646 (67.01)
Opium consumption-no. (%)0.0010.2270.583<0.001
 Yes168 (19.11)60 (20.62)230 (22.89)307 (31.85)
 No711 (80.89)231 (79.38)775 (77.11)657 (68.15)
Diabetes-no. (%)0.0410.013<0.001<0.001
 Yes195 (10.10)74 (3.83)302 (15.66)281 (14.56)
 No1735 (89.90)1856 (96.17)1627 (84.34)1649 (85.44)
Family history of hypertension in first-degree relatives-no (%)0.6580.4690.9040.117
 Yes492 (55.78)168 (3.08)558 (10.24)509 (52.69)
 No390 (44.22)126 (96.92)4890 (89.76)457 (47.31)
Family history of hypertension in second-degree relatives-no (%)0.6430.0240.0380.003
 Yes149 (16.89)34 (2.10)142 (8.78)125 (12.94)
 No733 (83.11)1583 (97.90)1475 (91.22)841 (87.06)
Fatty liver-no. (%)<0.001<0.001<0.0010.409
 Yes167 (18.93)53 (18.03)165 (16.34)106 (10.97)
 No715 (81.07)241 (81.97)845 (83.66)860 (89.03)
Use of hepatotoxic drugs-no. (%)0.2070.254<0.001<0.001
 Yes197 (22.34)79 (26.87)315 (31.19)304 (31.47)
 No685 (77.66)215 (73.13)695 (68.81)662 (68.53)
Cholesterol-no. (%)<0.0010.003<0.001<0.001
 Normal394 (44.32)141 (47.32)433 (42.53)487 (50.05)
 Elevated495 (55.68)157 (52.68)585 (57.47)486 (49.95)
Triglycerides-no. (%)<0.0010.005<0.001<0.001
 Normal557 (62.65)203 (68.12)596 (58.55)662 (68.04)
 Elevated332 (37.35)95 (31.88)422 (41.45)311 (31.96)
LDL cholesterol-no. (%)<0.001<0.001<0.0010.001
 Normal633 (71.28)201 (67.68)699 (68.73)712 (73.25)
 Elevated255 (28.72)96 (32.32)318 (31.27)260 (26.75)
HDL cholesterol-no. (%)0.8550.4790.6790.594
 Normal885 (99.55)296 (99.33)1013 (99.51)970 (99.69)
 Reduced4 (0.45)2 (0.67)5 (0.49)3 (0.31)
FBS-no. (%)<0.001<0.001<0.001<0.001
 Normal677 (76.15)217 (72.82)696 (68.37)682 (70.09)
 Elevated212 (23.85)81 (27.18)322 (31.63)291 (29.91)

Abbreviations: BMI: body mass index; FBS: fasting blood sugar; AST: aspartate aminotransferase; ALT: alanine aminotransferase; ALP: alkaline phosphatase; GGt: γ-glutamyl transferase; WSI: Wealth score index.